New tools for coronary risk assessment: what are their advantages and limitations?

Area of Science:

• Cardiology
• Preventive Medicine
• Public Health

Background:

• Risk assessment and reduction are fundamental to preventive cardiology.
• Coronary heart disease (CHD) risk factors guide the intensity of preventive interventions.
• Established risk factors include cholesterol, blood pressure, smoking, diabetes, and age.

Purpose of the Study:

• To highlight the importance of risk factor assessment in tailoring preventive cardiology strategies.
• To discuss the role of aggressive risk factor reduction in primary prevention.
• To explore novel methods for atherosclerosis monitoring and risk assessment.

Main Methods:

• Review of conventional coronary heart disease risk factors.
• Evaluation of noninvasive imaging modalities for atherosclerosis detection (e.g., exercise ECG, CT, MRI, PET, ABI, ultrasound).
• Assessment of novel serum markers (e.g., C-reactive protein, homocysteine) for risk stratification.

Main Results:

• Conventional risk factors guide therapeutic strategies in preventive cardiology.
• Noninvasive imaging can monitor atherosclerosis in asymptomatic individuals.
• Novel serum markers offer additional risk assessment capabilities.
• Systemic risk reduction therapy may be superior to local interventions for preventing acute coronary events.

Conclusions:

• Aggressive risk factor reduction is crucial for high-risk primary prevention.
• Noninvasive imaging and novel biomarkers enhance risk assessment and monitoring.
• Systemic therapies are potentially more effective than invasive procedures for primary prevention of coronary events.